德美化工(002054.SZ)前三季度净利润预增95.07%-143.84%
格隆汇8月28日丨德美化工(002054.SZ)在2019年半年度报告中披露,预计2019年前三季度归属于上市公司股东的净利润6800万元至8500万元,同比增长95.07%至143.84%;业绩变动的原因:
主要是因中炜化工经营模式改变亏损减少、皮化经营业绩改善,以及存货盘亏及资产处置损失同比减少所致。
因同一控制下合并德荣化工追溯调整后,2018年7-9月实现归属于上市公司股东的净利润764.05万元;2019年7-9月归属于上市公司股东的净利润预计同比增长124%至346%
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.